交易 BioNTech BNTX

出售
 購買

BioNTech實時圖表

5m 15m 30m 1h 4h 1d 1w

金融工具基礎知識

Weekly Search
Weekly
Daily
日期  關閉 更改 更改(%)： 開倉 高 低

最新新聞

Christine Voong 2024 Dec 30, 10:23

日圓兌美元跌至五個月低點，市場關注日圓匯率未來走勢及政策干預可能

Christine Voong 2024 Dec 30, 05:21

美股迎來輝煌2024，投資人展望2025年政策與美國經濟數據影響市場走向

So Ze Dong 2024 Dec 30, 01:00

美股年末走勢回顧全年表現亮眼，市場期待 “聖誕行情” 即將來領

Christine Voong 2024 Dec 27, 08:19

年終市場交投清淡，黃金價格走勢持穩，本週有望小幅收高

Christine Voong 2024 Dec 27, 05:32

亞洲股市普遍走高，日本股市大漲；中國經濟數據改善，南韓面臨政治危機

Christine Voong 2024 Dec 27, 04:05

美股漲跌分化：道瓊斯工業指數連漲五日，納斯達克與S&P 500指數則小幅回落；科技巨頭股受公債收益率壓力表現分化

So Ze Dong 2024 Dec 26, 16:00

投資者關注假期短週美股市場表現，2025年標普500指數或將突破7000點

So Ze Dong 2024 Dec 26, 16:00

分析師表示《比特幣儲備法案》很有可能影響比特幣減半週期

聯絡方式

點差

0.7801

點差(%)

0.8393 %

槓桿

1:10

隔夜利息（買入）

-0.0597 %

隔夜利息（賣出）

-0.0292 %

貨幣

USD

交易時間

市場關閉

星期五

13:31 - 19:59

星期一

13:31-19:59

星期二

13:31-19:59

星期三

13:31-19:59

星期四

13:31-19:59

分析與統計

開倉

---

上一次平倉

---

52 週高點/低點

--- – ---

市值

23202729984

流通股份

240392992

收益日期（下一個）

0000-00-00

現金殖利率 

2022-06-17

除息日

2022-06-02

遠期年股息率

0

遠期年現金殖利率

0

每股盈餘

-3.03

了解有關此金融工具的詳細資訊

BioNTech BioNTech SE
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany. The company develops BNT111, which is in Phase 2 clinical trial for advance melanoma; BNT113, which is in Phase 2 clinical trial to treat head and neck squamous cell carcinoma; BNT116, which is in Phase I clinical trial for non-small cell lung cancer; BNT142, which is in phase 1/2 clinical trial for multiple solid tumors; BNT151, which is in phase 1/2 clinical trial for solid tumors; BNT152+BNT153, which is in phase 1 clinical trial for solid tumors; and BNT122/RO7198457, which is in Phase 2 clinical trial to treat adjuvant high-risk muscle-invasive urothelial carcinoma, colorectal cancer, pancreatic ductal adenocarcinoma, advance melanoma, as well as in phase 1a/1b clinical trial for advanced/metastatic solid tumors. It also develops BNT211, which is in phase 1 clinical trial to treat CLDN6+ solid tumors; BNT221, phase 1 clinical trial for the treatment of cancer; BNT311/GEN1046 (acasunlimab), which is in phase 3 clinical trial for solid tumors; BNT312/GEN1042, which is in phase 1/2 and 1 clinical trial to treat solid tumors; BNT314/GEN1059, which is in Phase 1/2 clinical trial for advanced or metastatic solid tumors; BNT315/GEN1055, which is in phase 1/2 clinical trial for advanced solid tumors; BNT317, which is in phase 1 clinical trial for advanced solid tumors; BNT327, which is in phase 1/2, 2, and 3 clinical trial to treat small cell lung cancer, advanced/metastatic tnbc, neuroendocrine neoplasm, malignant mesothelioma, EGFR-mutant non-squamous, hepatocellular carcinoma, and advanced solid tumors; and BNT316/ONC-392, which is in phase 1/2, 2, and 3 clinical trial to treat metastatic, non-small cell lung cancer, platinum-resistant ovarian cancer, metastatic castration resistant prostate cancer, and advanced or metastatic solid tumor. BioNTech SE was incorporated in 2008 and is headquartered in Mainz, Germany.

相關工具

資產
出售
購買
更改(%)：

立即交易

立即交易

立即交易

立即交易
查看所有金融工具
Trustpilot
RequestMessages17TimelineExceptionsViews0RouteQueries0Models0MailsGateSession
SettingsRequest history38.1.18PHP Version17.64msRequest Duration2MBMemory UsageGET params
status
200 OK
full_url
https://web-qa.staging.markets.com/params
controller_action
App\Http\Controllers\TrackingParams@fetch
Theme
Open Button Position
Hide Empty Tabs
Autoshow
Reset to defaults
status
200 OK
full_url
https://web-qa.staging.markets.com/params
action_name
controller_action
App\Http\Controllers\TrackingParams@fetch
uri
GET params
controller
App\Http\Controllers\TrackingParams@fetch
file
app/Http/Controllers/TrackingParams.php:11-31
middleware
web
duration
17.83ms
peak_memory
2MB
response
application/json
request_format
html
request_query
[]
request_request
[]
request_headers
  0 of 0   
array:14 [▼
  "cookie" => array:1 [▶
    0 => "mktv4_ip_override=zh-tw; mktloc=eyJpdiI6ImNUWFJWcWNXWkorWWR0TDQxOC9EMnc9PSIsInZhbHVlIjoiRDZxNFN2Tk0vMU9TQ29KM3FmSE1EZXRabFFScEFHOUlKZmFmcE1XQUJiRml2VUtMVWxuUE94T2t3UE85VVROTiIsIm1hYyI6IjBjN2ZkZTVmNDc3Mzg3YzczZDM4YTQ0NmRjNzVlNTgzMDYyYTNmOTlmYTBmYTYyMzlkZmQ2NzJiYmU5ZGQ0MjkiLCJ0YWciOiIifQ%3D%3D; firstURL=https://web-qa.staging.markets.com/zh-tw/instrument/lemonade/; lastURL=https://web-qa.staging.markets.com/zh-tw/instrument/lemonade/; intent_group=%252Fzh-tw%252Finstrument%252Fbiontech%252F; intent_instrument=biontech; XSRF-TOKEN=eyJpdiI6InlMVHhPcDBQbk5wTk51dmhZU3VGamc9PSIsInZhbHVlIjoiZHFXbWZVdHQ4dmxmTjREcDBMOCtVMm5mZ0R3QjRLMUlocnJvcFQ1L0I3aWRHMWJ0WkhubTRueUw1KzFueVlucjhDUXBZRVBmZDI2eHJJL3gyQm1NOHRNcEd4ckpQL1BTWXBMY3UycTU5YXBkQkxHZW93bkwzeUhSOE1sRHQvK0EiLCJtYWMiOiIwODZiNDY3YzAxODVmOTdkZDQ3NWFjOWUyOTg4ZjZjM2NjZDE1ZWRiOGU5ZmU5ODAxMDY2OGFlM2QwZWY2NjRiIiwidGFnIjoiIn0%3D; laravel_session=eyJpdiI6IkFGSDFFaHQ5WGhVSmZXUXpWL2p1OVE9PSIsInZhbHVlIjoiZndPeHRFdFVHc1RYcmdZR2ZKUnl6NWJLRGc1eHdxYlN0K0JzbHQ3U0JUdUd5MkhHT0lGcnVyUFNLNHJmL002RTNOTHBDOXRXRFlQOXBJWUNhdDlKRk5CeUFqOTczSGM5UlBiaTFLcVl5di8ycm9xc0Z0bmdmNmNqYlFzSkJKeWMiLCJtYWMiOiI1YTM1OWI2YjE4ZDIyODgzN2M0OWEyMDhhZmQ1Zjg2NTM0YmRlZDkyZmRmZGZhNzZiM2U4Zjc1NjEwMzBmOTU2IiwidGFnIjoiIn0%3D ◀mktv4_ip_override=zh-tw; mktloc=eyJpdiI6ImNUWFJWcWNXWkorWWR0TDQxOC9EMnc9PSIsInZhbHVlIjoiRDZxNFN2Tk0vMU9TQ29KM3FmSE1EZXRabFFScEFHOUlKZmFmcE1XQUJiRml2VUtMVWxuUE94 ▶"
  ]
  "accept-encoding" => array:1 [▶
    0 => "gzip, deflate, br, zstd"
  ]
  "sec-fetch-dest" => array:1 [▶
    0 => "empty"
  ]
  "sec-fetch-mode" => array:1 [▶
    0 => "cors"
  ]
  "sec-fetch-site" => array:1 [▶
    0 => "same-origin"
  ]
  "accept" => array:1 [▶
    0 => "*/*"
  ]
  "sec-ch-ua-mobile" => array:1 [▶
    0 => "?0"
  ]
  "sec-ch-ua" => array:1 [▶
    0 => ""HeadlessChrome";v="129", "Not=A?Brand";v="8", "Chromium";v="129""
  ]
  "user-agent" => array:1 [▶
    0 => "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)"
  ]
  "sec-ch-ua-platform" => array:1 [▶
    0 => ""Windows""
  ]
  "cache-control" => array:1 [▶
    0 => "no-cache"
  ]
  "pragma" => array:1 [▶
    0 => "no-cache"
  ]
  "connection" => array:1 [▶
    0 => "keep-alive"
  ]
  "host" => array:1 [▶
    0 => "web-qa.staging.markets.com"
  ]
]
request_cookies
  0 of 0   
array:8 [▼
  "mktv4_ip_override" => null
  "mktloc" => "us,us"
  "firstURL" => null
  "lastURL" => null
  "intent_group" => null
  "intent_instrument" => null
  "XSRF-TOKEN" => "cuutAy9XtKzk9F6vSGWguuiQFYLxGssZMB3z5yCY"
  "laravel_session" => "VBynavmzSGjStVKF0tzXKINSaMBtXV2oJvotqqQZ"
]
response_headers
  0 of 0   
array:3 [▼
  "cache-control" => array:1 [▶
    0 => "no-cache, private"
  ]
  "date" => array:1 [▶
    0 => "Mon, 14 Apr 2025 09:30:43 GMT"
  ]
  "content-type" => array:1 [▶
    0 => "application/json"
  ]
]
session_attributes
  0 of 0   
array:4 [▼
  "_token" => "cuutAy9XtKzk9F6vSGWguuiQFYLxGssZMB3z5yCY"
  "PHPDEBUGBAR_STACK_DATA" => []
  "_previous" => array:1 [▶
    "url" => "https://web-qa.staging.markets.com/params"
  ]
  "_flash" => array:2 [▶
    "old" => []
    "new" => []
  ]
]
    • Booting (15.62ms)time
    • Application (2ms)time
    • Routing (454μs)
    • 1 x Booting (88.59%)
      15.62ms
      1 x Application (11.36%)
      2.00ms
      1 x Routing (2.57%)
      454μs
      0 templates were rendered
        uri
        GET params
        middleware
        web
        controller
        App\Http\Controllers\TrackingParams@fetch
        file
        app/Http/Controllers/TrackingParams.php:11-31
        0 statements were executed0μs
              _token
              cuutAy9XtKzk9F6vSGWguuiQFYLxGssZMB3z5yCY
              PHPDEBUGBAR_STACK_DATA
              []
              _previous
              array:1 [ "url" => "https://web-qa.staging.markets.com/params" ]
              _flash
              array:2 [ "old" => [] "new" => [] ]
              ClearShow all
              Date ↕MethodURLData
              #12025-04-14 09:30:41GET/zh-tw/instrument/biontech/1771
              #22025-04-14 09:30:43GET/csrf/ (ajax)
              #32025-04-14 09:30:43GET/params/ (ajax)